(Unless otherwise stated, all abbreviations and definitions used herein shall have the same meaning as those used in the Company's announcements dated 27 February 2018, 30 March 2018, 11 April 2018 and30 April 2018 in relation to the Proposed Bonus Issue and Proposed DRP)

The Board of Directors of CCM Duopharma Biotech Berhad ("CCM Duopharma") wishes to announce that the shareholders of CCM Duopharmahave approved the ordinary resolutionsin relationto (I) the Proposed Bonus Issue; and (II) the Proposed DRP as set out in the Notice of Extraordinary General Meeting ("EGM") dated 30 April 2018 at the EGM held earlier today.

The voting in respect of the ordinary resolutions was carried out by way of poll and the result was validated by Asia Securities Sdn Berhad, the independent scrutineer appointed by CCM Duopharma.

Please refer to the Appendix 1for the results of the poll.

This Announcement is dated 31 May2018.